Paralysis case and contact spread of recombinant vaccine-derived poliovirus, Spain.
Avellón
Ana
A
Cabrerizo
Maria
M
de Miguel
Teresa
T
Pérez-Breña
Pilar
P
Tenorio
Antonio
A
Pérez
Jose Luis
JL
de Aragón
Maria Victoria Martínez
MV
Trallero
Gloria
G
D000293:Adolescent; D000328:Adult; D036022:Capsid Proteins / Q000235:genetics; D002648:Child; D004196:Disease Outbreaks; D017809:Fatal Outcome; D006801:Humans; D016867:Immunocompromised Host; D007223:Infant; D008297:Male; D010243:Paralysis / Q000821:virology*; D011051:Poliomyelitis / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control / Q000635:transmission*; D011055:Poliovirus Vaccine, Oral / Q000008:administration & dosage / Q000009:adverse effects* / Q000235:genetics; D017386:Sequence Homology, Amino Acid; D013030:Spain / Q000453:epidemiology; D014611:Vaccination / Q000009:adverse effects* / Q000592:standards; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000009:adverse effects / Q000235:genetics
D036022:Capsid Proteins; D011055:Poliovirus Vaccine, Oral; C442540:VP1 protein, Poliovirus; D014614:Vaccines, Synthetic